66 results
Page 2 of 4
8-K
EX-99.1
3m5ff92s
10 Jan 22
Other Events
8:00am
8-K
EX-99.1
k51pw wjym1ev5tuqqsk
10 Nov 21
Axcella Therapeutics Reports Third Quarter Financial Results and Provides Update on Long COVID, OHE and NASH Clinical Trials
8:08am
8-K
EX-99.1
407ms35h 6dhc7t
29 Jul 21
Axcella Reports Second Quarter Financial Results and Provides Business Update
7:58am
8-K
EX-99.1
oo8rdr
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.2
brfan2rm8n2fg94
6 May 21
Axcella Reports First Quarter Financial Results and Provides Business Update
7:51am
8-K
EX-99.1
mogg1tih67g9g7243p41
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
EX-99.1
s8qbr9
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
o7iwfb
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-10.1
vsge41mbid
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
EX-99.1
nngr3hszj5716nu
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am
8-K
EX-99.1
qk33a3iw9h xva
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
424B5
ltc5 phw1znj
12 Jun 20
Prospectus supplement for primary offering
4:31pm